Essentia Health Remer Clinic Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 9 Birch St Ne, Remer, MN 56672 Phone: 218-566-1441 |
News Archive
Janssen Therapeutics, Division of Janssen Products, LP, presented today 96-week findings from two pivotal Phase 3 clinical trials, known as ECHO and THRIVE, comparing the efficacy, safety and virology profile of its non-nucleoside reverse transcriptase inhibitor EDURANT tablets versus efavirenz (EFV) in antiretroviral treatment-naive, HIV-1-infected adults.
A post-holiday crush of patients are crowding into area physician offices and hospital emergency rooms as individuals of all ages suddenly find themselves laid low by a highly contagious and quick-striking virus.
Clinical and Laboratory Standards Institute (CLSI) recently published "Validation of Automated Systems for Immunohematological Testing Before Implementation; Approved Guideline" (I/LA33-A). This document provides guidance to laboratory personnel for validating an automated system for immunohematological testing before implementation.
Nearly 20 years ago, it was discovered that bacteria known as Helicobacter pylori were responsible for stomach ulcers. Since then, antibiotics have become the primary therapy used to combat the H. pylori infection, which affects approximately six percent of the world population and is also a primary cause of stomach cancer. But today the bacteria is growing increasingly resistant to antibiotics.
Two separate studies presented today at The International Liver Congress 2016 in Barcelona, Spain have offered alternative conclusions regarding the efficacy of direct-acting antivirals (DAAs) among patients co-infected with HIV and Hepatitis C virus (HCV).
› Verified 3 days ago